SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-16-111140
Filing Date
2016-04-13
Accepted
2016-04-13 09:00:39
Documents
9
Period of Report
2016-05-25
Effectiveness Date
2016-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a16-6292_2def14a.htm DEF 14A 472831
2 GRAPHIC g62922bci001.gif GRAPHIC 2558
3 GRAPHIC g62922bci002.jpg GRAPHIC 1947
4 GRAPHIC g62922bci003.jpg GRAPHIC 1965
5 GRAPHIC g62922bci004.gif GRAPHIC 2148
6 GRAPHIC g62922bci005.gif GRAPHIC 2540
7 GRAPHIC g62922bci006.gif GRAPHIC 1862
8 GRAPHIC g62921cai001.gif GRAPHIC 75935
9 GRAPHIC g62921cai002.gif GRAPHIC 33230
  Complete submission text file 0001104659-16-111140.txt   643324
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 161568460
SIC: 2834 Pharmaceutical Preparations